Philippe Mondon

Heteroresistance to Fluconazole and Voriconazole in <i>Cryptococcus neoformans</i>

Philippe Mondon, R Petter, Guido Amalfitano et al. · Antimicrobial Agents and Chemotherapy · 1999 · 140 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies

Mathilde Bas, Aurélie Terrier, Émilie Jacque et al. · The Journal of Immunology · 2019 · 82 citations

Life Sciences, Biochemistry, Molecular Biology +17

Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis

Philippe Mondon, Christophe de Champs, A Donadille et al. · Journal of Medical Microbiology · 1996 · 50 citations

Life Sciences, Infectious Diseases, Microbiology +17

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions

Céline Monnet, Sylvie Jorieux, Nathalie Fournier et al. · Frontiers in Immunology · 2015 · 48 citations · Full text

Life Sciences, Immunology, Pharmaceutical Biotechnology +15

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody

Céline Monnet, Sylvie Jorieux, Nathalie Souyris et al. · mAbs · 2014 · 48 citations · Full text

Pharmacy, Biotechnology, Immunology +17